Liminatus Pharma, Inc. (LIMN) stock
LIMNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMNW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$2.81−0.16 (-5.39%)
Close on Nov 17, 2026Market cap $188.72MP/E –Yield –
Liminatus Pharma gross margin
Gross margin is gross profit as a percentage of revenue.
No gross margin figures for Liminatus Pharma
Liminatus Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?